105 related articles for article (PubMed ID: 7864230)
21. Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats.
Gao H; Welch WJ; DiBona GF; Wilcox CS
Am J Physiol; 1997 Aug; 273(2 Pt 2):H734-9. PubMed ID: 9277490
[TBL] [Abstract][Full Text] [Related]
22. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
Spurney RF; Middleton JP; Raymond JR; Coffman TM
Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
Williams SP; Dorn GW; Rapoport RM
Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
[TBL] [Abstract][Full Text] [Related]
24. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
25. Characterization of thromboxane receptor blocking effects of SQ 29548 in the feline pulmonary vascular bed.
McMahon TJ; Hood JS; Nossaman BD; Hyman AL; Kadowitz PJ
J Appl Physiol (1985); 1992 Mar; 72(3):1194-200. PubMed ID: 1533211
[TBL] [Abstract][Full Text] [Related]
26. Thromboxane A2 receptor mediation of calcium and calcium transients in rat cardiomyocytes.
Dogan S; Turnbaugh D; Zhang M; Cofie DQ; Fugate RD; Kem DC
Life Sci; 1997; 60(12):943-52. PubMed ID: 9061051
[TBL] [Abstract][Full Text] [Related]
27. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Ogletree ML; Allen GT
J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
[TBL] [Abstract][Full Text] [Related]
28. TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons.
Hsu KS; Huang CC; Kan WM; Gean PW
Am J Physiol; 1996 Oct; 271(4 Pt 1):C1269-77. PubMed ID: 8897834
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
Fukunaga M; Yura T; Grygorczyk R; Badr KF
Am J Physiol; 1997 Apr; 272(4 Pt 2):F477-83. PubMed ID: 9140048
[TBL] [Abstract][Full Text] [Related]
30. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.
Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL
J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
Seale JP; Nourshargh S; Hellewell PG; Williams TJ
Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
[TBL] [Abstract][Full Text] [Related]
32. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
Shams G; Wallace LJ; Miller DD; Feller DR
Pharmacology; 1990; 40(1):27-32. PubMed ID: 2139513
[TBL] [Abstract][Full Text] [Related]
33. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
34. [Extravascular transfer of fluids and proteins induced by endothelin in the binephrectomized rat].
Valentin JP; Gardner DG; Ribstein J; Mimran A; Humphreys MH
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1159-62. PubMed ID: 1835358
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary vasodilation to adrenomedullin: a novel peptide in humans.
Heaton J; Lin B; Chang JK; Steinberg S; Hyman A; Lippton H
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2211-5. PubMed ID: 7611471
[TBL] [Abstract][Full Text] [Related]
36. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia.
Slotman GJ; Yellin SA; Handy JR; Hulstyn M; Husain SE; Gann DS
Surgery; 1986 Aug; 100(2):214-21. PubMed ID: 3526603
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats.
Kriston T; Venuto RC; Baylis C; Losonczy G
Am J Physiol; 1999 Mar; 276(3):R831-7. PubMed ID: 10070145
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
40. Analysis of responses to serotonin in the pulmonary vascular bed of the cat.
McMahon TJ; Hood JS; Nossaman BD; Kadowitz PJ
J Appl Physiol (1985); 1993 Jul; 75(1):93-102. PubMed ID: 8104177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
